Medicxi Ventures Management (Jersey) Ltd

13F Filings History

Latest 13F report
Q3 2024 - Oct 15, 2024
Value $
$529M
Notable people
Kevin Stuart Johnson, Francesco De Rubertis, Michele Ollier
Signature - Title
Giles Johnstone-Scott - Director
Location
St. Helier, Jersey
Summary
This page shows a list of all the recent 13F filings made by Medicxi Ventures Management (Jersey) Ltd. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Medicxi Ventures Management (Jersey) Ltd reported 4 stock holdings with total value $529M as of Q3 2024. Top holdings included CNTA, PHAT, NAMS, and AURA.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2024 4 $529M $0 $0 CNTA, PHAT, NAMS, AURA 13F-HR 10/15/2024, 01:22 PM
Q2 2024 4 $335M $0 -$52.6M -$52.6M CNTA, PHAT, NAMS, AURA 13F-HR 7/16/2024, 04:31 PM
Q1 2024 5 $449M +$39.3M -$19.4M +$19.9M CNTA, PHAT, NAMS, MRUS, AURA 13F-HR 4/15/2024, 12:28 PM
Q4 2023 5 $296M $0 -$53.5M -$53.5M CNTA, MRUS, PHAT, NAMS, AURA 13F-HR 2/1/2024, 08:43 AM
Q3 2023 6 $313M $0 -$13.5M -$13.5M CNTA, PCVX, PHAT, MRUS, AURA 13F-HR 10/18/2023, 09:39 AM
Q2 2023 6 $357M +$28.6M -$7.08M +$21.5M CNTA, PCVX, PHAT, MRUS, AURA 13F-HR 7/19/2023, 11:04 AM
Q1 2023 6 $233M $0 $0 CNTA, PCVX, MRUS, AURA, NAMS 13F-HR 4/27/2023, 08:51 AM
Q4 2022 6 $238M +$21.8M -$20.6M +$1.17M PCVX, CNTA, AURA, PHAT, MRUS 13F-HR 1/31/2023, 04:16 PM
Q3 2022 5 $240M +$372K -$2.53M -$2.16M CNTA, AURA, PCVX, MRUS, PHAT 13F-HR 10/25/2022, 09:00 AM
Q2 2022 6 $241M +$3.23M -$4.79M -$1.56M CNTA, AURA, PCVX, MRUS, PHAT Restatement 8/3/2022, 11:09 AM
Q1 2022 7 $369M +$16.5M $0 +$16.5M CNTA, AURA, PCVX, MRUS, PHAT 13F-HR 5/12/2022, 09:55 AM
Q4 2021 7 $400M +$53.9M $0 +$53.9M CNTA, AURA, MRUS, PCVX, PHAT 13F-HR 2/3/2022, 09:26 AM
Q3 2021 6 $460M $0 $0 CNTA, PHAT, PCVX, MRUS, CMPI 13F-HR 11/10/2021, 12:47 PM
Q2 2021 6 $558M +$398M $0 +$398M CNTA, PHAT, PCVX, MRUS, CMPI 13F-HR 8/3/2021, 06:15 AM
Q1 2021 5 $172M $0 $0 PHAT, PCVX, MRUS, CMPI, OBSVF 13F-HR 5/11/2021, 11:40 AM
Q4 2020 5 $172M $0 $0 PHAT, PCVX, MRUS, CMPI, OBSVF 13F-HR 2/12/2021, 08:49 AM
Q3 2020 5 $209M +$17.3M $0 +$17.3M PCVX, PHAT, MRUS, CMPI, OBSVF 13F-HR 10/27/2020, 11:30 AM
Q2 2020 4 $163M +$59.7M $0 +$59.7M PHAT, PCVX, MRUS, OBSVF 13F-HR 8/7/2020, 06:05 AM
Q1 2020 3 $76.5M $0 -$70.3M -$70.3M PHAT, MRUS, OBSVF 13F-HR 5/12/2020, 12:01 PM
Q4 2019 4 $163M $0 $0 THOR, PHAT, MRUS, OBSVF 13F-HR 2/11/2020, 09:40 AM